Michael Burgess: “I know some stakeholders view these laws as a barrier to value-based payment reform.”

I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.

It is now my great privilege and high honor to yield 3 minutes to the gentleman from Texas (Mr. Arrington), the chairman of the Budget Committee, as we debate the first bipartisan budget bill to pass the floor of the House I think in the…

I never expected that CMMI was actually going to deliver the cost savings that was promised.

I am pleased to yield 4 minutes to the gentleman from Missouri (Mr. Alford) for his comments.